GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (OTCPK:CNTMF) » Definitions » YoY EPS Growth

CNTMF (Cansortium) YoY EPS Growth : -100.00% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Cansortium's YoY EPS Growth for the quarter that ended in Sep. 2024 was -100.00%.

Cansortium's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $-0.04.

Cansortium YoY EPS Growth Historical Data

The historical data trend for Cansortium's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium YoY EPS Growth Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial -8,900.00 50.00 55.56 -87.50 46.67

Cansortium Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 50.00 66.67 115.00 -100.00

Cansortium YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Cansortium's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-0.08--0.15)/ | -0.15 |
=46.67 %

Cansortium's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-0.04--0.02)/ | -0.02 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cansortium YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Cansortium's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cansortium Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (OTCPK:CNTMF) » Definitions » YoY EPS Growth
Comparable Companies
TSXV:ZYUS XCNQ:AYR.A TSXV:HASH XCNQ:INNO TSXV:LOVE XCNQ:LEEF XCNQ:JUSH TSX:MDP TSX:XLY XCNQ:GWAY ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
2WM:Germany TIUM.U:Canada
Address
82 North East 26th Street, Unit 110, Miami, FL, USA, 33137
Website
https://getfluent.com
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.